Comment from Huntington's Disease Society of America

Summary: The Huntington’s Disease Society of America (HDSA) supports the National Priority Voucher Pilot Program as a means to accelerate transformative treatments for rare diseases like Huntington’s. They urge the FDA to establish clear eligibility criteria, incorporate disease-specific expertise into evaluations, and ensure adequate staffing to maintain review quality.